Table of contents

May 2005 Volume 2 No 5

Top

Editorial

Atrial fibrillation: an epidemiologic, scientific and clinical challenge

Valentin Fuster

225

doi:10.1038/ncpcardio0199 | Full Text | PDF (49K)


Top

Viewpoint

Anticoagulants for stroke prevention in atrial fibrillation: what is the right rate and where do we go from here?

Alan S Go

226

Atrial fibrillation affects millions of people worldwide and significantly increases the risk of ischemic stroke. In this month's Viewpoint, Alan Go examines the use of anticoagulant therapy, the problems faced and future therapeutic options for the prevention of stroke in patients with atrial fibrillation.

doi:10.1038/ncpcardio0198 | Full Text | PDF (69K)


Top

Research Highlights

Does distal microcirculatory protection improve PCI results?

228

doi:10.1038/ncpcardio0174 | Full Text | PDF (54K)

Benefits of cardiac resynchronization therapy

228

doi:10.1038/ncpcardio0175 | Full Text | PDF (54K)

Does aspirin protect women against cardiovascular disease?

228

doi:10.1038/ncpcardio0176 | Full Text | PDF (61K)

Predicting outcome in patients with asymptomatic mitral regurgitation

229

doi:10.1038/ncpcardio0177 | Full Text | PDF (54K)

High-risk acute coronary syndromes: cost-effectiveness of clopidogrel plus aspirin

229

doi:10.1038/ncpcardio0178 | Full Text | PDF (62K)

Right-ventricular function after acute myocardial infarction

230

doi:10.1038/ncpcardio0179 | Full Text | PDF (55K)

Obstructive sleep apnea-hypopnea and cardiovascular risk

230

doi:10.1038/ncpcardio0180 | Full Text | PDF (62K)

Acute myocardial infarction: invasive versus medical treatment

231

doi:10.1038/ncpcardio0181 | Full Text | PDF (54K)

Prognostic value of BNP in heart failure

231

doi:10.1038/ncpcardio0182 | Full Text | PDF (61K)

Value of screening for abdominal aortic aneurysms

232

doi:10.1038/ncpcardio0183 | Full Text | PDF (54K)

Leukocyte count in cardiovascular risk assessment

232

doi:10.1038/ncpcardio0184 | Full Text | PDF (54K)

Do thiazide diuretics increase the risk of gallbladder disease?

232

doi:10.1038/ncpcardio0185 | Full Text | PDF (60K)

HOPE-TOO results: vitamin E supplements do not protect against cancer or cardiovascular disease

233

doi:10.1038/ncpcardio0186 | Full Text | PDF (53K)


Top

Practice Points

Can niacin slow the development of atherosclerosis in coronary artery disease patients already taking statins?

B Greg Brown

234

doi:10.1038/ncpcardio0189 | Full Text | PDF (70K)

Does losartan reduce the risk of stroke in patients with hypertension?

Thomas Unger

236

doi:10.1038/ncpcardio0197 | Full Text | PDF (71K)

Can the measurement of impaired flow-mediated dilation predict in-stent restenosis?

Matthew I Worthley, Francois Charbonneau and Todd J Anderson

238

doi:10.1038/ncpcardio0188 | Full Text | PDF (70K)

Is self-management of oral anticoagulation a feasible and safe option?

Jack E Ansell

240

doi:10.1038/ncpcardio0193 | Full Text | PDF (72K)

Can intravascular ultrasound detect left main coronary artery disease accurately?

Paul Schoenhagen

242

doi:10.1038/ncpcardio0191 | Full Text | PDF (72K)

Does reducing a patient's CRP levels with statin therapy reduce their risk of recurrent cardiovascular events?

Cornelis Kluft

244

doi:10.1038/ncpcardio0196 | Full Text | PDF (70K)


Top

Reviews

Continuing Medical Education

Atherosclerosis of the ascending aorta as a major determinant of the outcome of cardiac surgery

Per Bergman and Jan van der Linden

246

Stroke is an important complication of cardiac surgery. The degree of risk is significantly influenced by the presence, extent and location of atherosclerosis in the ascending aorta. Per Bergman and Jan van der Linden provide an overview of the current perioperative measures that can be taken to lessen this risk.

doi:10.1038/ncpcardio0192 | Full Text | PDF (113K)

Therapy Insight: heart disease and the insulin-resistant patient

Stuart A Cook, Tim Aitman and Rossi P Naoumova

252

Patients with insulin resistance syndromes are at an increased risk of developing cardiovascular disease. This review discusses the relationship between insulin resistance and heart disease, and describes how aggressive risk factor management and multifactoral treatment approaches are being used to improve the clinical outcomes of these patients.

doi:10.1038/ncpcardio0194 | Full Text | PDF (203K)

Technology Insight: randomized trials of off-pump versus on-pump coronary artery bypass surgery

Thoralf M Sundt

261

Coronary artery bypass grafting can now be performed without the use of the cardiopulmonary bypass pump, a technique known as "off-pump" coronary bypass. Despite data from nonrandomized retrospective trials showing a benefit to the off-pump technique, skepticism remains. This review discusses the evidence to date, focusing on data from prospectively randomized studies.

doi:10.1038/ncpcardio0190 | Full Text | PDF (127K)


Extra navigation

.

ADVERTISEMENT